Haven't Lost Any Weight on Mounjaro? What to Check (October 2026)

01 · The core answer

Haven't lost weight on Mounjaro: is this normal?

Yes, in the early weeks it is very often normal. The 2.5mg starting weeks are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal.¹

Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ The dose steps up after at least 4 weeks on each dose, depending on how you respond and tolerate it, so the dose that works for you may still be ahead of you.

02 · What to decide

The decisions you are actually facing

Most readers are choosing between three paths: wait, adjust your routine, or speak to the prescriber. Which one fits depends on how long you have been treating and which dose you are on.

Notice that none of these paths involves taking more medicine than prescribed. A plateau is not a reason to double doses or add unlicensed products.¹

03 · Next step

What to do next

Start by writing down your current dose, how many weeks you have been on it, and what you are eating on a typical day. That gives you and your prescriber something concrete to discuss. If you are an existing customer, your ongoing monthly review is the right place to raise it, and the prescribing team can advise on titration and side-effect support.

A new customer's first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and all six doses are in stock. Every prescription is reviewed by a GPhC-registered prescriber.

For wider support beyond the injection itself, our weight loss clinic page explains how treatment, diet and activity fit together. Mounjaro is a prescription-only medicine, used alongside a reduced-calorie diet and increased physical activity, and individual results vary.¹

Related guides: Not lost any weight on mounjaro and Not losing any weight on mounjaro.

04 · The starter weeks

Why the starter weeks rarely show much

The 2.5mg starting weeks are about adjustment, and experiences differ widely.¹ Some people feel their appetite change and see early loss in week one. Others feel almost nothing until a higher dose. Both are normal, and neither tells you how the next months will go.

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes, and it comes as a pre-filled multi-dose pen in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ The lowest strength is the first rung of a ladder, not the destination. It exists so your body can get used to the medicine before the dose rises.

Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.¹ This cuts both ways. A quick early drop may partly be fluid and can look like it stalls afterwards. A flat early scale can hide changes in appetite and eating patterns that will pay off as the dose rises. Weigh yourself under the same conditions, ideally at the same time of day, and look at the direction over several weeks rather than day to day.

The commonest early effects are mild nausea, altered appetite and tiredness in the first days after each injection, and they usually settle.¹ Different people notice different things at different times.

It also helps to check the practical side. Follow the pen's instructions each week, inject on your usual day, and keep your pens as the patient information leaflet describes. Unopened pens are stored in the fridge until first use and keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away.¹ If you are unsure about technique or storage, ask the pharmacy or your prescriber rather than guessing.

The main message is patience: weight loss on Mounjaro is gradual by design, so think in months, not days.¹

What you can do in these weeks is build habits that make later doses work harder for you. Eat regular meals even when appetite is low, keep protein in each meal, stay active in a way you enjoy, and notice when you feel full. These are the routines the medicine is designed to support, and they will matter more as the dose goes up. Treat the starter weeks as training for the months ahead rather than as a test you are failing.

05 · The dose ladder

Dose, titration and why 2.5mg is not the working dose

Most measurable progress builds from 5mg onward, month by month, so staying on a starter dose and expecting large changes sets you up for disappointment.¹ People often ask whether they can stay on 2.5mg and still lose weight.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Look at what that says about the ladder. The averages rise with dose. They were measured at 72 weeks, which is many months of treatment. A person on the lowest strength for a short time is nowhere near the conditions in which those averages were reached. Comparing your first weeks with a headline figure is therefore not a fair test.

Whether and when to step up is your prescriber's decision, based on how you are tolerating treatment and responding.

That is why the experience on 2.5mg can feel very different from higher strengths.

If you are already on a mid-range dose and see little change, do not assume you must jump to the top. Discuss it at your review. Your prescriber can weigh your tolerability, your eating pattern and how long you have been on the current dose. A step-up is appropriate only if you are not yet at maximum and the prescriber agrees; it is never something to do by yourself.

A new customer's first order of any strength is £40 less with code FIRST40, and every later order is £25 off the standard price. You can see the current prices on the Mounjaro pen page.

06 · Realistic expectations

What realistic progress looks like by three months

Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures.² In SURMOUNT-1, average weight loss built month by month, with the full 15–21% averages measured at 72 weeks, not 12.² If you measure yourself against the end of the trial at the start of treatment, almost everyone will look like they are behind.

A sensible three-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.² Wide variation means some people will be well above that and some below, including some who have seen little. Your result is not a verdict on you; it is a data point that your prescriber can interpret alongside your dose history.

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Those are long-run figures across a trial population, so they describe what became possible over time, not what any individual should see in the first weeks.

A worked example makes the scale clearer without projecting a timeline. For someone starting at 100 kg, 20.9% is about 21 kg. That is the trial average on 15mg at 72 weeks, not a target and not a promise for you. Trial averages do not predict your own result.

It is also useful to know the trials ran alongside lifestyle support. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² If your intake has not changed, the medicine's effect on appetite may be less visible than you hoped. That is not a failing; it is a prompt to look at what you are eating and how often.

Many readers arrive after seeing others post fast results. Social media shows the most dramatic stories, not the typical ones. Other people's pace says little about yours, because starting weight, dose, tolerability, sleep, stress and eating patterns all differ. If you want a balanced view of what treatment can do, our guide on how much weight Mounjaro can help you lose sets the trial evidence out in context.

Use the trend. Take a weekly measurement rather than daily ones, add a waist or clothing check, and review it each month with your prescriber. Judge progress by trend, not individual weigh-ins.¹ A flat fortnight inside a longer downward trend is nothing to worry about, while a flat run of months at an adequate dose is worth a proper conversation.

07 · Plateaus and checks

Plateaus: what to check when the scale stalls

Weight loss on Mounjaro is not linear; plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹ If you have lost some weight and then stopped, that is a different situation from never having lost any, but the same toolkit applies. Within the licence, there are four responses worth working through in order.

Review food intake honestly. Portions drift back up. When appetite is quieter it is easy to eat a little more often or a little more per sitting, and drinks, snacks and extras add up without feeling like meals. Keep a plain record for a week or two, with no judgement, and you will probably see where intake has crept.

Protect protein and activity. Protein at each meal and regular movement help you keep muscle while the weight comes off, and they support the way you feel day to day. You do not need an extreme programme. A routine you can keep doing is better than a punishing plan you abandon.

Check the basics: sleep and alcohol. Poor sleep and regular alcohol can both work against your progress, and alcohol adds calories that do not fill you up. These are not moral failings; they are ordinary factors worth adjusting before assuming the medicine is the problem.

Discuss a dose step-up with your prescriber if you are not yet at maximum.¹ If you have been on the same dose for a long time and nothing has changed, that conversation is a normal part of your monthly review, and the prescribing team can advise on titration.

What not to do is just as important. A plateau is not a reason to double doses or add unlicensed products.¹ Supplements marketed as natural alternatives make dramatic weight-loss claims but do not offer the clinical oversight or evidence of a licensed treatment. If something promises a quick fix, be sceptical.

A plateau can also feel worse when you are tracking obsessively. Daily weights fluctuate with water, salt, hormones and digestion. Moving to a weekly weigh-in under the same conditions often calms the picture and shows the real direction. Our related pages on a week with no change and on weekly weigh-ins that do not move go through this in more detail.

Finally, remember that people respond differently. Some are slower responders, and the right answer is a structured review over time rather than a rush to change something. Tell your prescriber about any side effects, changes in appetite, difficulty eating enough, or other medicines you take, because all of those can affect how treatment is planned.

08 · Looking slimmer

Looking slimmer but the scale has not moved

A smaller waist or looser clothes without a change on the scale is a reason to measure more than just weight. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises, but they show that the scale is only one window onto what treatment is doing.

That is why prescribers talk about weight management as health management rather than appearance. If your waist is smaller, your clothes fit differently or your blood pressure and blood-sugar readings are improving, those are meaningful changes even when the number on the scales sits still. Ask your GP or prescriber whether routine measurements of these are due.

The scale can lag for ordinary reasons. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.¹ Fluid shifts from salt, hormones, travel, constipation or a heavy meal can easily mask real change from one day to the next. If you are active, you may also be building muscle while losing fat, which can keep the scale steady while your shape changes.

Practical ways to see the whole picture include:

• Measure your waist at the same point each month, rather than relying on the scale alone.
• Take a photo in similar clothing and light at regular intervals.
• Note how clothes fit, how you feel climbing stairs and how your appetite behaves.
• Record any health readings your clinician has asked you to track.
• Use a tracking tool such as our free GLPTrackr companion app to keep dose dates and measurements in one place.

None of these replace medical review, but together they make a plateau feel less alarming and give your prescriber more to work with.

It is also fair to say when the scale does matter. If you have been on an adequate dose for a sustained period, are following your plan, and see neither a change on the scale nor in your waist or health readings, that is the situation your prescriber's formal review exists for. Do not wait in silence. Bring your measurements, your food notes and your dose history to the conversation, and ask directly whether continuing or stopping is the right call.

People sometimes ask why they are still losing weight after changes such as a lower dose or a gap in treatment. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system, and there is no way to speed this up.¹ Effects can therefore linger for a while after the last injection.

09 · When to call your prescriber

When to speak to your prescriber about response

Speak to your prescriber whenever your progress worries you, and always at your scheduled reviews, because treatment response is formally reviewed over time. The clinical framework is clear: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹

Notice the wording carefully. It refers to the highest tolerated dose, not to the lowest dose and not to a dose you have been on briefly. If you are still near the start of the ladder, that review point has not yet arrived, and the right move is usually to continue the planned titration. If you have reached the highest dose you can tolerate and have followed the plan, the review becomes relevant.

Individual response varies, and trial averages do not predict your own result.

The mechanism helps explain the limits. Tirzepatide activates two natural gut-hormone receptors, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve how the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ Notice the phrase: it supports a reduced-calorie diet. The medicine is not a fat burner on its own; the licensed approach is to combine treatment with eating less and moving more.

Useful things to bring to a review:

• Your current dose and how many weeks you have been on it.
• Your weight and waist measurements over time, not just the latest reading.
• An honest account of eating, drinks, snacks and alcohol.
• Any side effects, such as nausea or low appetite that makes eating enough difficult.
• Any other medicines you take, including for diabetes, because some may need dose adjustments.

Existing customers have ongoing monthly reviews, dose titration and follow-up assessments with the prescribing team, plus side-effect support. Repeat orders re-check suitability, and there is no auto-shipping, so you stay in control of when you reorder. Support is available Monday to Friday, and you can raise concerns by email, account chat or phone.

If you are not an existing customer and are worried about a medicine from another source, talk to the prescriber who supplied it. Never source tirzepatide from sellers offering to supply without a consultation or prescription, as counterfeit products are a recognised risk flagged by the MHRA.⁷

10 · Safety and Yellow Card

Side effects, safety and reporting new symptoms

Not losing weight is rarely a safety problem, but how you feel on treatment always matters. The commonest early effects are mild nausea, altered appetite and tiredness in the first days after each injection, and they usually settle.¹ If effects are stronger or longer-lasting than that, or you cannot eat enough, tell your prescriber rather than waiting. Struggling to eat can slow progress and affect how you feel, so it is a legitimate reason to ask for a review.

Tell your prescriber about any new or lasting symptom. You can also report suspected side effects through the MHRA Yellow Card scheme, which helps monitor the safety of medicines in the UK.¹⁹ You do not need to be certain the medicine caused a symptom to raise it. Reporting is how patterns are noticed.

Tirzepatide can reduce absorption of oral contraceptives because stomach emptying slows, so ask your prescriber about contraception if it applies to you. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹

Because the question "why is it not working" often leads people to take matters into their own hands, it is worth being direct about what to avoid:

• Do not double doses or inject more often than prescribed.
• Do not add unlicensed products or supplements marketed with dramatic weight-loss claims.
• Do not buy from sellers who offer to supply without a consultation or prescription.
• Do not stop and restart treatment on your own without telling your prescriber.

Each of these moves outside the licensed approach and can add risk without a proven benefit. A plateau is not a reason to double doses or add unlicensed products.¹

If you have a medicine from us, it comes from official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. Orders are reviewed by a GPhC-registered prescriber, and unsuitable orders are refunded automatically. We are registered with the General Pharmaceutical Council under number 9012878, and you can confirm that on the public register.¹²

Finally, remember that Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and used alongside a reduced-calorie diet and increased physical activity. Individual results vary, and this page is information, not a substitute for medical advice. For severe, persistent stomach pain, swelling of the face, lips or throat, difficulty breathing or yellowing of the skin or eyes, get medical help straight away.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

12 · NHS and private routes

NHS and private treatment: where reviews happen

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Whichever route you use, the same clinical principle applies: treatment is monitored, response is reviewed, and the dose is adjusted by a prescriber. Not losing weight in the early weeks is handled the same way in both settings. The prescriber looks at your dose, your tolerability, how long you have been treating and what else is going on, then decides whether to continue, adjust or stop.

If you are on the NHS pathway and feel your progress is slow, raise it at your scheduled appointments, and ask what support exists for diet and activity alongside the medicine. NHS programmes often include structured lifestyle support, which matters because treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

If you are using private treatment, make sure you are getting real clinical follow-up rather than a one-off sale. With us, ongoing monthly clinical reviews are included, repeat orders re-check suitability, and the prescribing team handles dose titration and follow-up assessments. There are no subscriptions, and you can pay by Visa or Mastercard, with Klarna and pay-monthly options available. The price shown is the price paid, and the consultation is free.

Ordering follows a simple path: a free online consultation with a short health questionnaire, a review by a GPhC-registered prescriber, dispensing and dispatch by our registered pharmacy, and free next-day tracked delivery in temperature-controlled, discreet packaging. Orders placed by 3pm are dispatched the same day, and Saturday delivery costs £14.99. Needles, a sharps bin and injection guidance come with every order. You can start from the Mounjaro pen page.

For context, across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 depending on dose and provider, as of 11 October 2026. Compare the whole programme, not just the pen price.

NHS prescriptions in England carry a charge of £9.90 per item for those who pay, so ask your GP about your situation. If your sense is that you are not responding, the answer in every setting is the same: bring evidence, ask for a structured review, and decide the next step with your prescriber.